25+ min ago   (1324+ words) Statistics cookies help us to understand how visitors interact with websites by collecting and reporting information anonymously. Marketing cookies allow us to display more relevant ads that are engaging for our users and thereby, they are more valuable for publishers…...

3+ day, 7+ hour ago   (379+ words) Meredith McKean, MD, MPH, of Sarah Cannon Research Institute in Nashville, Tennessee, shares commentary on updates in melanoma presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. Meredith McKean, MD, MPH: Hi, I am Meredith McKean. I’m a…...

3+ day, 3+ hour ago   (213+ words) First Patient Dosing to Begin This Year, Phase 3 IND Filing Planned for Next Year Domestic Vaccine Self-Sufficiency and Proprietary mRNA-LNP Platform Sovereignty GC Biopharma said on the 11th that the Ministry of Food and Drug Safety had approved the investigational new…...

3+ day, 10+ hour ago   (522+ words) If all goes well, a major advance in preventing the spread of melanoma, the deadliest skin cancer, could be just months away from U.S. Food and Drug Administration approval. Moderna and Merck announced on Aug. 19 that a major phase 3 clinical trial…...

4+ day, 2+ hour ago   (830+ words) The first results supporting the use of a personalised cancer vaccine in patients with completely resected melanoma have been announced. Pharmaceutical companies MSD and Moderna have announced a positive outcome for their phase 3 trial comparing an investigational and individualised mRNA…...

4+ day, 7+ hour ago   (82+ words) WCVB Dermatologist talks new melanoma vaccine in trial stages Dermatologist Dr. Abby Waldman said the new melanoma vaccine doesn't prevent melanoma, but it is meant to prevent recurrence in patients with very high-stage melanoma. Iowa marching band member dies after…...

5+ day, 14+ hour ago   (129+ words) Dr. Jad Chahoud of the Orlando Health Cancer Institute joins WESH 2 to discuss the new melanoma vaccine now showing potential in reducing the recurrence of skin cancer. A new melanoma vaccine is demonstrating promising results in clinical trials, offering hope…...

5+ day, 21+ hour ago   (535+ words) Moderna and Merck report positive Phase 3 melanoma results for intismeran, but the benefit’s numerical size, durability and approval status remain limited. INTerpath-001 was a randomized, double-blind, global Phase 3 trial with placebo and active-comparator controls. It enrolled 1,137 people with completely resected…...

6+ day, 32+ min ago   (682+ words) SAN DIEGO -- Intismeran Autogene, a vaccine that treats melanoma, a deadly type of skin cancer, has made headlines worldwide. Recently reported results indicate that the personalized medication, taken in combination with the immunotherapy Keytruda, met its main goal, reducing the…...

6+ day, 13+ hour ago   (442+ words) An Oxford University cancer firm is celebrating a $500K investment from one of its shareholders, which will allow it to continue its research. Dr Tony Coombs, chair of Oxford Vacmedix UK Limited, a company based at Oxford Science Park, said he…...